Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine

被引:27
作者
Findlow, H
Southern, J
Mabey, L
Balmer, P
Heyderman, RS
Auckland, C
Morris, R
Miller, E
Borrow, R
机构
[1] Manchester Royal Infirm, Vaccine Evaluat Unit, Hlth Protect Agcy NW, Manchester M13 9WZ, Lancs, England
[2] Univ Bristol, Dept Pathol & Microbiol, Bristol, Avon, England
[3] HPA Ctr Infect, Immunisat Dept, London, England
[4] Gloucester HPA, Gloucester Vaccine Evaluat Unit, Gloucester, England
[5] Bristol HPA Lab, Bristol, Avon, England
关键词
D O I
10.1128/CVI.13.4.507-510.2006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Changes in the immunoglobulin G1 (IgG1)/IgG2 ratio following vaccination can indicate the activation of cellular control mechanisms typical of a T-cell-dependent response. We examined IgG subclass ratios in 17 healthy adults (26 to 55 years of age) before and 4 to 6 weeks following immunization with a quadrivalent meningococcal-polysaccharide diphtheria toxoid conjugate vaccine against serogroups A, C, Y, and W135. Serologic responses were determined by serum bactericidal antibody assay and serogroup-specific IgG, IgG1, and IgG2 enzyme-linked immunosorbent assay. Prevaccination serogroup A-specific IgG1/IgG2 ratios were < 1 for all subjects and differed by subject for C, Y, and W-135. Postvaccination, significant increases in IgG, IgG1, and IgG2, were observed for all serogroups. Serogroup-specific IgG1/IgG2 ratios increased for group A (14/17 subjects, 88%), decreased in more than half of subjects for groups C (9/17, 53%) and W135 (12/17, 71%) and decreased for serogroup Y (16/17, 94%). IgG1/gG2 ratios differed between individual vaccinees and were similar to the responses of adults who received pneumococcal conjugate vaccines or a monovalent C conjugate vaccine. Further studies on IgG subclasses following meningococcal polysaccharide and conjugate vaccination are needed.
引用
收藏
页码:507 / 510
页数:4
相关论文
共 20 条
[1]
Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England [J].
Andrews, N ;
Borrow, R ;
Miller, E .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (05) :780-786
[2]
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: Reevaluation of correlates of protection [J].
Borrow, R ;
Andrews, N ;
Goldblatt, D ;
Miller, E .
INFECTION AND IMMUNITY, 2001, 69 (03) :1568-1573
[3]
Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults [J].
Campbell, JD ;
Edelman, R ;
King, JC ;
Papa, T ;
Ryall, R ;
Rennels, MB .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (12) :1848-1851
[4]
MULTICENTER COMPARISON OF LEVELS OF ANTIBODY TO THE NEISSERIA-MENINGITIDIS GROUP-A CAPSULAR POLYSACCHARIDE MEASURED BY USING AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
CARLONE, GM ;
FRASCH, CE ;
SIBER, GR ;
QUATAERT, S ;
GHEESLING, LL ;
TURNER, SH ;
PLIKAYTIS, BD ;
HELSEL, LO ;
DEWITT, WE ;
BIBB, WF ;
SWAMINATHAN, B ;
ARAKERE, G ;
THOMPSON, C ;
PHIPPS, D ;
MADORE, D ;
BROOME, CV .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (01) :154-159
[5]
Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults [J].
Goldblatt, D ;
Borrow, R ;
Miller, E .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (03) :397-400
[6]
ASSIGNMENT OF NEISSERIA-MENINGITIDIS SEROGROUP-A AND SEROGROUP-C CLASS-SPECIFIC ANTICAPSULAR ANTIBODY CONCENTRATIONS TO THE NEW STANDARD REFERENCE SERUM CDC1992 [J].
HOLDER, PK ;
MASLANKA, SE ;
PAIS, LB ;
DYKES, J ;
PLIKAYTIS, BD ;
CARLONE, GM .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (02) :132-137
[7]
Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin a in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with chitosan [J].
Huo, ZM ;
Sinha, R ;
McNeela, EA ;
Borrow, R ;
Giemza, R ;
Cosgrove, C ;
Heath, PT ;
Mills, KHG ;
Rappuoli, R ;
Griffin, GE ;
Lewis, DJM .
INFECTION AND IMMUNITY, 2005, 73 (12) :8256-8265
[8]
RESPONSE TO OLIGOSACCHARIDE PROTEIN CONJUGATE VACCINE AGAINST HAEMOPHILUS-INFLUENZAE-B IN 2 PATIENTS WITH IGG2 DEFICIENCY UNRESPONSIVE TO CAPSULAR POLYSACCHARIDE VACCINE [J].
INSEL, RA ;
ANDERSON, PW .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (08) :499-503
[9]
Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera [J].
Joseph, H ;
Balmer, P ;
Bybel, M ;
Papa, T ;
Ryall, R ;
Borrow, R .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (01) :1-5
[10]
Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents [J].
Keyserling, H ;
Papa, T ;
Koranyi, K ;
Ryall, R ;
Bassily, E ;
Bybel, MJ ;
Sullivan, K ;
Gilmet, G ;
Reinhardt, A .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2005, 159 (10) :907-913